These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2971219)

  • 1. The role of thromboxane A2 in reperfusion injury.
    Grover GJ; Sleph PG; Parham C
    Proc Soc Exp Biol Med; 1988 Sep; 188(4):504-8. PubMed ID: 2971219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the thromboxane receptor antagonist SQ 29,548 on myocardial infarct size in dogs.
    Grover GJ; Schumacher WA
    J Cardiovasc Pharmacol; 1988 Jan; 11(1):29-35. PubMed ID: 2450253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of the thromboxane A2/prostaglandin endoperoxide receptor antagonist SQ 30,741 on myocardial infarct size and blood flow during myocardial ischemia and reperfusion.
    Grover GJ; Schumacher WA; Simon M; Parham C
    J Cardiovasc Pharmacol; 1988 Dec; 12(6):701-9. PubMed ID: 2467089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of the thromboxane A2 receptor antagonist SQ 29,548 on the severity of pacing-induced ischemia.
    Grover GJ; Schumacher WA
    Basic Res Cardiol; 1989; 84(1):103-10. PubMed ID: 2522297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective actions of a thromboxane receptor antagonist, SQ 29548 on the ischemic myocardium: morphologic and hemodynamic effects.
    Singh J; Seth SD; Manchanda SC; Seth S
    Prostaglandins Leukot Essent Fatty Acids; 1997 Feb; 56(2):105-10. PubMed ID: 9051718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the thromboxane A2 receptor antagonist SQ 30,741 on ultimate myocardial infarct size, reperfusion injury and coronary flow reserve.
    Grover GJ; Schumacher WA
    J Pharmacol Exp Ther; 1989 Feb; 248(2):484-91. PubMed ID: 2521899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous prostaglandin endoperoxides may alter infarct size in the presence of thromboxane synthase inhibition: studies in a rabbit model of coronary artery occlusion-reperfusion.
    Golino P; Ambrosio G; Villari B; Ragni M; Focaccio A; Pace L; de Clerk F; Condorelli M; Chiariello M
    J Am Coll Cardiol; 1993 Feb; 21(2):493-501. PubMed ID: 8426016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of thromboxane A2 in the control of myocardial O2 supply/consumption balance and severity of ischemia during pacing-induced ischemia.
    Grover GJ; Parham CS
    Circ Res; 1989 Mar; 64(3):575-82. PubMed ID: 2917381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cardioprotective effects of the thromboxane receptor antagonist SQ 30,741 are not reversed by aspirin.
    Grover GJ; Parham CS; Schumacher WA
    Basic Res Cardiol; 1991; 86(2):99-106. PubMed ID: 1831610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboxane receptor blockade with SQ 30,741 improves post-ischemic myocardial function in anesthetized dogs.
    Grover GJ
    Proc Soc Exp Biol Med; 1989 Oct; 192(1):56-60. PubMed ID: 2529546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboxane A2 antagonist and diltiazem-induced enhancement of contractile function: the effect of timing of treatment.
    Grover GJ; Fulmor IE
    J Pharmacol Exp Ther; 1988 Nov; 247(2):445-52. PubMed ID: 3183946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of thromboxane receptor blockade on oxygen supply/consumption variables during reperfusion in the anesthetized dog.
    Grover GJ; Sleph PG; Weiss HR
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1097-102. PubMed ID: 2141635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin S2 and thromboxane A2-prostaglandin H2 receptor blockade provide protection against epinephrine-induced cyclic flow variations in severely narrowed canine coronary arteries.
    Ashton JH; Golino P; McNatt JM; Buja LM; Willerson JT
    J Am Coll Cardiol; 1989 Mar; 13(3):755-63. PubMed ID: 2521875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosis.
    Golino P; Rosolowsky M; Yao SK; McNatt J; De Clerck F; Buja LM; Willerson JT
    J Clin Invest; 1990 Oct; 86(4):1095-102. PubMed ID: 2145320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial salvage efficacy of the thromboxane receptor antagonist ifetroban in ferrets and dogs.
    Gomoll AW; Grover GJ; Ogletree ML
    J Cardiovasc Pharmacol; 1994 Dec; 24(6):960-8. PubMed ID: 7898080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of oral pretreatment with metoprolol on left ventricular wall motion, infarct size, hemodynamics, and regional myocardial blood flow in anesthetized dogs during thrombotic coronary artery occlusion and reperfusion.
    Zmudka K; Dubiel J; Vanhaecke J; Flameng W; De Geest H
    Cardiovasc Drugs Ther; 1994 Jun; 8(3):479-87. PubMed ID: 7947365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combined antiischemic effects of the thromboxane receptor antagonist SQ 30,741 and tissue-type plasminogen activator.
    Grover GJ; Parham CS; Schumacher WA
    Am Heart J; 1991 Feb; 121(2 Pt 1):426-33. PubMed ID: 1825008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined thromboxane A2 synthetase inhibition and receptor blockade are effective in preventing spontaneous and epinephrine-induced canine coronary cyclic flow variations.
    Yao SK; Rosolowsky M; Anderson HV; Golino P; NcNatt JM; De Clerck F; Buja LM; Willerson JT
    J Am Coll Cardiol; 1990 Sep; 16(3):705-13. PubMed ID: 2143767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in activities of thromboxane A2 receptor antagonists in smooth muscle cells.
    Miki I; Kase H; Ishii A
    Eur J Pharmacol; 1992 Oct; 227(2):199-204. PubMed ID: 1426029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of thromboxane and serotonin receptor antagonists on intracoronary platelet deposition in dogs with experimentally stenosed coronary arteries.
    Golino P; Buja LM; Ashton JH; Kulkarni P; Taylor A; Willerson JT
    Circulation; 1988 Sep; 78(3):701-11. PubMed ID: 3409505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.